US Patent Issued to IncreVet on April 15 for "Compound for the management of feline diabetes" (California, Massachusetts Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,689, issued on April 15, was assigned to IncreVet Inc. (Framingham, Mass.).

"Compound for the management of feline diabetes" was invented by Michael Hadd (San Jose, Calif.), Albert Collinson (Berlin, Mass.) and Brian Seed (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of managing feline diabetes, said methods include administering to a feline in need thereof a total daily dosage of about 5 to 50 mg of Compound 1, having the formula:or a pharmaceutically acceptable form thereof. Also provided herein are methods of managing feline diabetes by administering to a feline in need thereof an effective amount of a SGLT inh...